Report cover image

Global Antimicrobial Susceptibility Testing Market Size Study, by Product (Manual Tests, Automated Instruments, Consumables & Media), by Technique (Disk Diffusion, Automated AST, Etest Method, Others), by Application (Drug Development, Susceptibility Test

Publisher Bizwit Research & Consulting
Published Jan 11, 2025
Length 285 Pages
SKU # BIZW19502681

Description

Global Antimicrobial Susceptibility Testing Market Size Study, by Product (Manual Tests, Automated Instruments, Consumables & Media), by Technique (Disk Diffusion, Automated AST, Etest Method, Others), by Application (Drug Development, Susceptibility Testing, Others), by End-use (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, Others), and Regional Forecasts 2022-2032


The global Antimicrobial Susceptibility Testing (AST) market, valued at USD 3.42 billion in 2023, is projected to reach USD 5.35 billion by 2032, growing at a robust CAGR of 5.1% during the forecast period from 2024 to 2032. AST plays a pivotal role in combating antimicrobial resistance (AMR), a growing global health crisis caused by the overuse and misuse of antibiotics. This testing method enables healthcare providers to identify the most effective antimicrobial therapy, minimizing treatment failures and the spread of resistant pathogens.

The market's expansion is driven by the rising incidence of drug-resistant infections and an increasing focus on personalized medicine, where tailored treatments demand precise diagnostic solutions like AST. Government initiatives, such as the U.S. National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB) and the Global Antibiotic Resistance and Usage Surveillance System (GLASS), are further bolstering the adoption of AST technologies. These efforts reflect the global commitment to reducing AMR through improved diagnostics and therapeutic strategies.

Technological advancements, particularly in automated AST systems, are reshaping the industry landscape. Automated systems offer higher accuracy, reduced errors, and faster turnaround times compared to manual methods. Recent innovations, such as rapid AST solutions capable of delivering results within hours, are accelerating their adoption in clinical and research settings. Companies like NanoSynex Ltd. and COPAN Diagnostics are at the forefront, introducing next-generation AST tools to the market.

Regional dynamics reveal North America as the dominant market, supported by advanced healthcare infrastructure, a high prevalence of multidrug-resistant infections, and substantial investments in R&D. Meanwhile, the Asia-Pacific region is expected to exhibit the fastest growth, driven by increasing healthcare expenditures, growing awareness of AMR, and initiatives to modernize healthcare systems. Europe also plays a significant role, benefiting from supportive policies and a focus on technological innovation.

________________________________________

Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• BD (Becton, Dickinson, and Company)
• bioMérieux SA
• Danaher Corporation
• Bio-Rad Laboratories Inc.
• Merck & Co., Inc.
• Siemens Healthineers
• Creative Diagnostics
• F. Hoffmann-La Roche Ltd
• Hi-Media Laboratories Pvt. Ltd.
• ELITechGroup
• COPAN Diagnostics Inc.
• Agilent Technologies Inc.
• Beckman Coulter Inc.
• NanoSynex Ltd.

________________________________________

The detailed segments and sub-segments of the market are explained below:

By Product:
• Manual Tests
MIC Strips
Susceptibility Testing Disks
Susceptibility Plates
• Automated Instruments
• Consumables & Media

By Technique:
• Disk Diffusion
• Automated AST
• Etest Method
• Dilution
• Others

By Application:
• Drug Development
• Susceptibility Testing
• Others

By End-Use:
• Hospitals
• Diagnostic Laboratories
• Biotechnology & Pharmaceutical Companies
• Others

By Region:
• North America:
U.S.
Canada
• Europe:
U.K.
Germany
France
Spain
Italy
Sweden
Norway
Denmark
• Asia-Pacific:
China
India
Japan
South Korea
Australia
Thailand
• Latin America:
Brazil
Mexico
Argentina
• Middle East & Africa:
Saudi Arabia
South Africa
UAE
Kuwait

________________________________________

Years considered for the study are as follows:
• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032

Key Takeaways
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional-level analysis for each market segment.
• Detailed analysis of geographical landscape with country-level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approaches.
• Analysis of the competitive structure of the market.
• Demand-side and supply-side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

285 Pages
Chapter 1. Global Antimicrobial Susceptibility Testing Market Executive Summary
1.1. Global Antimicrobial Susceptibility Testing Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product
1.3.2. By Technique
1.3.3. By Application
1.3.4. By End-Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendations & Conclusion
Chapter 2. Global Antimicrobial Susceptibility Testing Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply-Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand-Side Analysis
2.3.4.1. Regulatory Frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Antimicrobial Susceptibility Testing Market Dynamics
3.1. Market Drivers
3.1.1. Increasing prevalence of antimicrobial resistance
3.1.2. Advancements in personalized medicine
3.1.3. Favorable government policies to combat AMR
3.2. Market Challenges
3.2.1. High costs of advanced AST systems
3.2.2. Limited standardization in AST techniques
3.3. Market Opportunities
3.3.1. Expansion of rapid AST technologies
3.3.2. Rising investments in healthcare infrastructure, especially in APAC
Chapter 4. Global Antimicrobial Susceptibility Testing Market Industry Analysis
4.1. Porter’s Five Forces Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top Investment Opportunities
4.4. Disruptive Trends
4.5. Industry Expert Perspectives
Chapter 5. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Product (2022-2032)
5.1. Segment Dashboard
5.2. Manual Tests
5.2.1. MIC Strips
5.2.2. Susceptibility Testing Disks
5.2.3. Susceptibility Plates
5.3. Automated Instruments
5.4. Consumables & Media
Chapter 6. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Technique (2022-2032)
6.1. Segment Dashboard
6.2. Disk Diffusion
6.3. Automated AST
6.4. Etest Method
6.5. Others
Chapter 7. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Application (2022-2032)
7.1. Segment Dashboard
7.2. Drug Development
7.3. Susceptibility Testing
7.4. Others
Chapter 8. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by End-Use (2022-2032)
8.1. Segment Dashboard
8.2. Hospitals
8.3. Diagnostic Laboratories
8.4. Biotechnology & Pharmaceutical Companies
8.5. Others
Chapter 9. Global Antimicrobial Susceptibility Testing Market Size & Forecasts by Region (2022-2032)
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.2. Europe
9.2.1. U.K.
9.2.2. Germany
9.2.3. France
9.2.4. Spain
9.2.5. Italy
9.2.6. Sweden
9.2.7. Norway
9.2.8. Denmark
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Thailand
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Argentina
9.5. Middle East & Africa
9.5.1. Saudi Arabia
9.5.2. South Africa
9.5.3. UAE
9.5.4. Kuwait
Chapter 10. Competitive Intelligence
10.1. Key Company SWOT Analysis
10.1.1. Thermo Fisher Scientific Inc.
10.1.2. BD (Becton, Dickinson, and Company)
10.1.3. bioMérieux SA
10.2. Top Market Strategies
10.3. Company Profiles
10.3.1. Thermo Fisher Scientific Inc.
10.3.2. BD (Becton, Dickinson, and Company)
10.3.3. Danaher Corporation
10.3.4. Bio-Rad Laboratories Inc.
10.3.5. Merck & Co., Inc.
10.3.6. Siemens Healthineers
10.3.7. Creative Diagnostics
10.3.8. COPAN Diagnostics Inc.
10.3.9. ELITechGroup
10.3.10. Hi-Media Laboratories Pvt. Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.2. Research Attributes
List of Tables
1. Global Antimicrobial Susceptibility Testing Market Size & Forecast, 2022–2032 (USD Billion)
2. North America Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022–2032 (USD Million)
3. Europe Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022–2032 (USD Million)
4. Asia-Pacific Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022–2032 (USD Million)
5. Latin America Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022–2032 (USD Million)
6. Middle East & Africa Antimicrobial Susceptibility Testing Market Size & Forecast by Country, 2022–2032 (USD Million)
7. Market Segmentation by Product, 2022–2032 (USD Million)
8. Manual Tests Market Size & Forecast, 2022–2032 (USD Million)
9. Automated Instruments Market Size & Forecast, 2022–2032 (USD Million)
10. Consumables & Media Market Size & Forecast, 2022–2032 (USD Million)
11. Market Segmentation by Technique, 2022–2032 (USD Million)
12. Disk Diffusion Market Size & Forecast, 2022–2032 (USD Million)
13. Automated AST Market Size & Forecast, 2022–2032 (USD Million)
14. Etest Method Market Size & Forecast, 2022–2032 (USD Million)
15. Market Segmentation by Application, 2022–2032 (USD Million)
16. Drug Development Market Size & Forecast, 2022–2032 (USD Million)
17. Susceptibility Testing Market Size & Forecast, 2022–2032 (USD Million)
18. End-Use Market Segmentation by Hospitals, 2022–2032 (USD Million)
19. Biotechnology & Pharmaceutical Companies Market Size & Forecast, 2022–2032 (USD Million)
20. List of Major Market Players and Market Share Analysis (2023)
This list is not complete; the final report contains over 100 tables. The list may be updated in the final deliverable.
List of Figures
1. Global Antimicrobial Susceptibility Testing Market Trends, 2022–2032
2. Market Segmentation by Product, 2023 (Share %)
3. Regional Analysis of Antimicrobial Susceptibility Testing Market, 2023 (Share %)
4. Market Segmentation by Technique, 2023 (Share %)
5. Automated Instruments Growth Rate (CAGR) by Region, 2024–2032
6. Technological Advancements in AST Systems, 2023 Overview
7. North America Antimicrobial Susceptibility Testing Market, Historical vs. Forecast, 2022–2032
8. APAC Antimicrobial Susceptibility Testing Market Growth Potential, 2023–2032
9. Porter’s Five Forces Analysis of the AST Market, 2023
10. PESTEL Analysis of Antimicrobial Susceptibility Testing Market, 2023
11. Competitive Market Share Analysis, 2023
12. SWOT Analysis of Thermo Fisher Scientific Inc.
13. SWOT Analysis of BD (Becton, Dickinson, and Company)
14. SWOT Analysis of bioMérieux SA
15. Top Strategies of Key Players in the AST Market, 2023
16. Global AMR Statistics Overview, 2023 (Cases by Region)
17. Share of Automated Instruments vs. Manual Tests, 2023
18. Role of AST in Drug Development Pipeline, 2023–2032
19. Regional Snapshot of Key Market Trends, 2023
20. Investment Trends in AST Technologies, 2024–2032
This list is not complete; the final report contains over 50 figures. The list may be updated in the final deliverable.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us